Fluidigm Corp
F:FLB
Fluidigm Corp
EPS (Diluted)
Fluidigm Corp
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Fluidigm Corp
F:FLB
|
EPS (Diluted)
$0
|
CAGR 3-Years
57%
|
CAGR 5-Years
24%
|
CAGR 10-Years
21%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
EPS (Diluted)
$17
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
14%
|
|
|
Danaher Corp
NYSE:DHR
|
EPS (Diluted)
$5
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
Waters Corp
NYSE:WAT
|
EPS (Diluted)
$10
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Agilent Technologies Inc
NYSE:A
|
EPS (Diluted)
$4
|
CAGR 3-Years
1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
EPS (Diluted)
$7
|
CAGR 3-Years
11%
|
CAGR 5-Years
41%
|
CAGR 10-Years
10%
|
|
Fluidigm Corp
Glance View
Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
See Also
What is Fluidigm Corp's EPS (Diluted)?
EPS (Diluted)
-0.2
USD
Based on the financial report for Dec 31, 2025, Fluidigm Corp's EPS (Diluted) amounts to -0.2 USD.
What is Fluidigm Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
21%
Over the last year, the EPS (Diluted) growth was 63%. The average annual EPS (Diluted) growth rates for Fluidigm Corp have been 57% over the past three years , 24% over the past five years , and 21% over the past ten years .
